Kuros Biosciences AG CSBTF Stock
Kuros Biosciences AG Price Chart
Kuros Biosciences AG CSBTF Financial and Trading Overview
| Kuros Biosciences AG stock price | 26.99 USD |
| Previous Close | 26.99 USD |
| Open | 27.45 USD |
| Bid | 24.8 USD x 20000 |
| Ask | 28.17 USD x 20000 |
| Day's Range | 24.55 - 27.45 USD |
| 52 Week Range | 22.72 - 42.81 USD |
| Volume | 85 USD |
| Avg. Volume | 51 USD |
| Market Cap | 1.07B USD |
| Beta (5Y Monthly) | 0.761 |
| PE Ratio (TTM) | 117.347824 |
| EPS (TTM) | 0.22 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CSBTF Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | 117.347824 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.1208935 |
| Price/Book (mrq) | 12.50695 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Kuros Biosciences AG Stock Price History
| Beta (5Y Monthly) | 0.761 |
| 52-Week Change | -21.72% |
| S&P500 52-Week Change | 18.67% |
| 52 Week High | 42.81 USD |
| 52 Week Low | 22.72 USD |
| 50-Day Moving Average | 25.87 USD |
| 200-Day Moving Average | 30.44 USD |
CSBTF Share Statistics
| Avg. Volume (3 month) | 51 USD |
| Avg. Daily Volume (10-Days) | 192 USD |
| Shares Outstanding | 39.67M |
| Float | 29.66M |
| Short Ratio | N/A |
| % Held by Insiders | 28.74% |
| % Held by Institutions | 22.00% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 5.12% |
| Operating Margin (ttm) | 5.60% |
| Gross Margin | 86.36% |
| EBITDA Margin | 7.64% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 174.93M USD |
| Revenue Per Share (ttm) | 4.56 USD |
| Quarterly Revenue Growth (yoy) | 45.50% |
| Gross Profit (ttm) | 151.08M USD |
| EBITDA | 13.38M USD |
| Net Income Avi to Common (ttm) | 8.9M USD |
| Diluted EPS (ttm) | 0.23 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 2.158 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Kuros Biosciences AG
| Country | United States |
| State | N/A |
| City | Schlieren |
| Address | Wagistrasse 25 |
| ZIP | 8952 |
| Phone | 41 44 733 4747 |
| Website | https://kurosbio.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 178 |
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bone grafts that mimic the porous and trabecular structure of cancellous bone, as well as checkmate licensing. The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.
Q&A For Kuros Biosciences AG Stock
What is a current CSBTF stock price?
Kuros Biosciences AG CSBTF stock price today per share is 26.99 USD.
How to purchase Kuros Biosciences AG stock?
You can buy CSBTF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kuros Biosciences AG?
The stock symbol or ticker of Kuros Biosciences AG is CSBTF.
Which industry does the Kuros Biosciences AG company belong to?
The Kuros Biosciences AG industry is Medical Devices.
How many shares does Kuros Biosciences AG have in circulation?
The max supply of Kuros Biosciences AG shares is 39.67M.
What is Kuros Biosciences AG Price to Earnings Ratio (PE Ratio)?
Kuros Biosciences AG PE Ratio is 122.68181600 now.
What was Kuros Biosciences AG earnings per share over the trailing 12 months (TTM)?
Kuros Biosciences AG EPS is 0.22 USD over the trailing 12 months.
Which sector does the Kuros Biosciences AG company belong to?
The Kuros Biosciences AG sector is Healthcare.
